Tag: Magazine Edition 20 Feb 2020

These articles also appear in the Global Biodefense Magazine – 20 February 2020 edition.

Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development

by Global Biodefense Staff

February 7, 2020

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug ...

CDC Updates Monkeypox Travel Alert for Nigeria

by Global Biodefense Staff

February 7, 2020

The U.S. Centers for Disease Control and Prevention (CDC) updates an existing Level 1 Travel Alert for Monkeypox in the ...

Page 4 of 4 Prev 1 … 3 4

About
Contact
Privacy
Subscribe

No Result

View All Result

Featured
COVID-19
Funding
Directory
Jobs
Events
Subscribe

Tag: Magazine Edition 20 Feb 2020

Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development

CDC Updates Monkeypox Travel Alert for Nigeria

Latest News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

Prioritizing Actions for Epidemic and Pandemic Preparedness

Prioritizing Actions for Epidemic and Pandemic Preparedness

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Subscribe